Related Experiment Video
Updated: Jun 25, 2025

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
Published on: July 17, 2020
Targeting ATP2B1 impairs PI3K/Akt/FOXO signaling and reduces SARS-COV-2 infection and replication
Pasqualino de Antonellis1,2,3, Veronica Ferrucci1,2,3, Marco Miceli1
1CEINGE Biotecnologie Avanzate, Naples, 80145, Italy.
Abstract:
ATP2B1 is a known regulator of calcium (Ca2+) cellular export and homeostasis. Diminished levels of intracellular Ca2+ content have been suggested to impair SARS-CoV-2 replication. Here, we demonstrate that a nontoxic caloxin-derivative compound (PI-7) reduces intracellular Ca2+ levels and impairs SARS-CoV-2 infection. Furthermore, a rare homozygous intronic variant of ATP2B1 is shown to be associated with the severity of COVID-19. The mechanism of action during SARS-CoV-2 infection involves the PI3K/Akt signaling pathway activation, inactivation of FOXO3 transcription factor function, and subsequent transcriptional inhibition of the membrane and reticulum Ca2+ pumps ATP2B1 and ATP2A1, respectively. The pharmacological action of compound PI-7 on sustaining both ATP2B1 and ATP2A1 expression reduces the intracellular cytoplasmic Ca2+ pool and thus negatively influences SARS-CoV-2 replication and propagation. As compound PI-7 lacks toxicity in vitro, its prophylactic use as a therapeutic agent against COVID-19 is envisioned here.
Insights
A novel compound, PI-7, lowers intracellular calcium levels, hindering SARS-CoV-2 replication and COVID-19 severity. This compound shows potential as a prophylactic therapeutic agent against the virus.
Area of Science:
- Molecular Biology
- Virology
- Pharmacology
Background:
- ATP2B1 regulates cellular calcium (Ca2+) export and homeostasis.
- Reduced intracellular Ca2+ levels may impede SARS-CoV-2 replication.
- A specific ATP2B1 variant is linked to COVID-19 severity.
Purpose of the Study:
- To investigate the effect of a caloxin-derivative compound (PI-7) on intracellular Ca2+ levels and SARS-CoV-2 infection.
- To elucidate the molecular mechanism underlying PI-7's action.
- To explore the therapeutic potential of PI-7 against COVID-19.
Main Methods:
- Assessing the impact of PI-7 on intracellular Ca2+ levels.
- Evaluating PI-7's efficacy in inhibiting SARS-CoV-2 infection in vitro.
- Analyzing the involvement of the PI3K/Akt/FOXO3 signaling pathway.
- Investigating the effect of PI-7 on ATP2B1 and ATP2A1 gene expression.
Main Results:
- Compound PI-7 effectively reduces intracellular Ca2+ levels.
- PI-7 demonstrates impairment of SARS-CoV-2 infection and propagation.
- A rare ATP2B1 intronic variant correlates with COVID-19 severity.
- PI-7 sustains ATP2B1 and ATP2A1 expression, reducing cytoplasmic Ca2+.
Conclusions:
- Compound PI-7 exhibits potential as a prophylactic therapeutic agent for COVID-19 due to its ability to reduce intracellular Ca2+ and inhibit viral replication.
- The mechanism involves modulation of the PI3K/Akt/FOXO3 pathway, impacting Ca2+ pump expression.
- PI-7's lack of in vitro toxicity supports its therapeutic consideration.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The JAK-STAT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
ATP Synthase: Mechanism

